Literature DB >> 23152569

Uncertainties in baseline risk estimates and confidence in treatment effects.

Frederick A Spencer1, Alfonso Iorio, John You, M Hassad Murad, Holger J Schünemann, Per O Vandvik, Mark A Crowther, Kevin Pottie, Eddy S Lang, Joerg J Meerpohl, Yngve Falck-Ytter, Pablo Alonso-Coello, Gordon H Guyatt.   

Abstract

Mesh：

Year:  2012        PMID： 23152569     DOI： 10.1136/bmj.e7401

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

1.  Some notes on critical appraisal of prevalence studies: Comment on: "The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence".

Authors:  Thomas Harder
Journal:  Int J Health Policy Manag       Date:  2014-10-11

Review 2.  Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.

Authors:  Bernat Kocsis; Ritchie E Brown; Robert W McCarley; Mihaly Hajos
Journal:  CNS Neurosci Ther       Date:  2013-04-24       Impact factor: 5.243

Review 3.  Ultrasound-guided lumbar medial branch blocks and intra-articular facet joint injections: a systematic review and meta-analysis.

Authors:  Zachary M Ashmore; Michael M Bies; James B Meiling; Rajat N Moman; Leslie C Hassett; Christine L Hunt; Steven P Cohen; W Michael Hooten
Journal:  Pain Rep       Date:  2022-05-16

4.  GRADE: Assessing the quality of evidence in environmental and occupational health.

Authors:  Rebecca L Morgan; Kristina A Thayer; Lisa Bero; Nigel Bruce; Yngve Falck-Ytter; Davina Ghersi; Gordon Guyatt; Carlijn Hooijmans; Miranda Langendam; Daniele Mandrioli; Reem A Mustafa; Eva A Rehfuess; Andrew A Rooney; Beverley Shea; Ellen K Silbergeld; Patrice Sutton; Mary S Wolfe; Tracey J Woodruff; Jos H Verbeek; Alison C Holloway; Nancy Santesso; Holger J Schünemann
Journal:  Environ Int       Date:  2016-01-27       Impact factor: 9.621

5.  GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.

Authors:  Holger J Schünemann; Carlos Cuello; Elie A Akl; Reem A Mustafa; Jörg J Meerpohl; Kris Thayer; Rebecca L Morgan; Gerald Gartlehner; Regina Kunz; S Vittal Katikireddi; Jonathan Sterne; Julian Pt Higgins; Gordon Guyatt
Journal:  J Clin Epidemiol       Date:  2018-02-09       Impact factor: 6.437

Review 6.  Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology.

Authors:  Kari A O Tikkinen; Arnav Agarwal; Samantha Craigie; Rufus Cartwright; Michael K Gould; Jari Haukka; Richard Naspro; Giacomo Novara; Per Morten Sandset; Reed A Siemieniuk; Philippe D Violette; Gordon H Guyatt
Journal:  Syst Rev       Date:  2014-12-23

7.  Implementing GRADE: calculating the risk difference from the baseline risk and the relative risk.

Authors:  Robert G Newcombe; Ralf Bender
Journal:  Evid Based Med       Date:  2013-08-22

Review 8.  Basing information on comprehensive, critically appraised, and up-to-date syntheses of the scientific evidence: a quality dimension of the International Patient Decision Aid Standards.

Authors:  Victor M Montori; Annie LeBlanc; Angela Buchholz; Diana L Stilwell; Apostolos Tsapas
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-29       Impact factor: 2.796

9.  Quantification of Treatment Effect Modification on Both an Additive and Multiplicative Scale.

Authors:  Nicolas Girerd; Muriel Rabilloud; Philippe Pibarot; Patrick Mathieu; Pascal Roy
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

10.  PRECEPT: an evidence assessment framework for infectious disease epidemiology, prevention and control.

Authors:  Thomas Harder; Anja Takla; Tim Eckmanns; Simon Ellis; Frode Forland; Roberta James; Joerg J Meerpohl; Antony Morgan; Eva Rehfuess; Holger Schünemann; Teun Zuiderent-Jerak; Helena de Carvalho Gomes; Ole Wichmann
Journal:  Euro Surveill       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.